Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis

Archives of Dermatological Research

Volumn 304, Issue 4, 2012, Pages 305-312

  Kou, Kenzen ^a   Aihara, Michiko ^a   Matsunaga, Tomoko ^a   Chen, Huichin ^a   Taguri, Masataka ^b   Morita, Satoshi ^b   Fujita, Hiroyuki ^a   Yamaguchi, Yukie ^a   Kambara, Takeshi ^b   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Adult atopic dermatitis; Eosinophils; Immunoglobulin E; Interleukin 18; Lactate dehydrogenase; SCORingAD; Thymus and activation regulated chemokine

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN E; INTERLEUKIN 18; LACTATE DEHYDROGENASE; STAPHYLOCOCCUS ENTEROTOXIN B; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ACCURACY; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EVENING DOSAGE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RELIABILITY; SCORING SYSTEM; SCORINGAD SCORE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL17; DERMATITIS, ATOPIC; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-18; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN; YOUNG ADULT;

EID: 84862886642     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1198-9     Document Type: Article

References (34)

1. Baumgrass R, Brandt C, Wegner F, Abdollahnia M, Worm M (2010) Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both. J Allergy Clin Immunol 126:183-184. doi:10.1016/j.jaci.2010. 04.032
2. Buggiani G, Ricceri F, Lotti T (2008) Atopic dermatitis. Dermatol Ther 21:96-100. doi:10.1111/j.1529-8019.2008.00176.x (Pubitemid 351499212)
3. Carmi-Levy I, Homey B, Soumelis V (2011) A modular view of cytokine networks in atopic dermatitis. Clinc Rev Allerg Immunol 41:245-253. doi:10.1007/s12016-010-8239-6
4. Furue M, Ohtsuki M, Ogata F, Ishibashi Y (1991) Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis. J Invest Dermatol 96:468-472. doi:10. 1111/1523-1747.ep12470153
5. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-876. doi:10.1172/JCI117408 (Pubitemid 24251022)
6. Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockholm) 92:44-47
7. Hijnen D, Haeck I, van Kraats AA, Nijhuis E, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Knol EF (2009) Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis. J Allergy Clin Immunol 124:856-858. doi: 10.1016/j.jaci.2009.07.056
8. Hon KL, Leung TF, Ma KC, Wong CK, Wan H, Lam CW (2004) Serum concentration of IL-18 correlates with disease extent in young children with atopic dermatitis. Pediatr Dermatol 21. 619-622. doi:10.1111/j.0736-8046.2004. 21600.x (Pubitemid 39657382)
9. Hoshino T, Wiltrout RH, Young HA (1999) IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-1. in modulating the immune response. J Immunol 162. 5070-507.
10. Inoue Y, Aihara M, Kirino M, Harada I, Komori-Yamaguchi J, Yamaguchi Y, Nagashima Y, Ikezawa Z (2011) Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with Staphylococcus aureus colonization. Br J Dermatol 164:560-567. doi:10.1111/j.1365-2133.2010.10145.x
11. Johnson EE, Irons JS, Patterson R, Roberts M (1974) Serum IgE concentration in atopic dermatitis. Relationship to severity of disease and presence of atopic respiratory disease. J Allergy Clin Immunol 54:94-99
12. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K (2001) Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107:535-541. doi:10.1067/mai.2001.113237 (Pubitemid 32210037)
13. Kakinuma T, Sugaya M, Nakamura K, Kaneko F, Wakugawa M, Matsushima K, Tamaki K (2003) Thymus and activationregulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48:23-30. doi:10.1067/mjd.2003.132 (Pubitemid 36091529)
14. Kakinuma T, Wakugawa M, Nakamura K, Hino H, Matsushima K, Tamaki K (2003) High level of thymus and activation-regulated chemokine in blister Xuid and sera of patients with bullous pemphigoid. Br J Dermatol 148:203-210. doi:10.1046/j.1365-2133. 2003.05066.x (Pubitemid 36278958)
15. Katsarou A, Armenaka MC (2011) Atopic dermatitis in older patients: particular points. J Eur Acad Dermatol Venerol 25:12-18. doi:10.1111/j.1468- 3083.2010.03737.x
16. Kim E, Lee JE, Namkung JH, Park JH, Kim S, Shin ES, Cho EY, Yang JM (2007) Association of the single-nucleotide polymorphism and haplotype of the interleukin 1. gene with atopic dermatitis in Koreans. Clin Exp Allergy 37:865-867. doi:10.1111/ j.1365-2222.2007.02717.x
17. Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, Nakanishi K, Mizutani H (2002) IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogenfree conditions. Proc Natl Acad Sci USA 99:11340-11345. doi:10.1073/pnas.152337799 (Pubitemid 34920927)
18. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195:10-19. doi:10.1159/000245677 (Pubitemid 27326702)
19. Kwakkel-van Erp JM, Haeck IM, Paantjens AW, van de Graaf EA, van Ginkel WG, Knol MJ, de Bruin-Weller MS, Lammers JW, Knol EF, Bruijnzeel-Koomen C, Otten HG (2010) Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. J Am Acad Dermatol 63:e70-e72. doi:10.1016/j.jaad.2010.02.015
20. Masutaka F, Yoichi K, Shoso Y (2005) Therapeutic guidelines for atopic dermatitis 2002. Allergol Int 54:45-49
21. Mukai H, Noguchi T, Kamimura K, Nishioka K, Nishiyama S (1990) Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J Dermatol 17:477-481 (Pubitemid 20327409)
22. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H (2003) Prevalence of atopic dermatitis in Japanese adults. Br J Dermatol 148:117-121. doi:10.1046/j.1365-2133. 2003.05092.x (Pubitemid 36114871)
23. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interlukin-1. regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474 (Pubitemid 32368042)
24. Okamura H, Tsutsi H, Komatsu T et al (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91
25. Park do S, Youn YH (2007) Clinical significance of serum interleukin-1. concentration in the patients with atopic dermatitis. Korean J Lab Med 27:128-132 (Korean). doi:10.3343/kjlm. 2007.27.2.128
26. Sohn MH, Lee KE, Kim KE (2004) Interleukin-18 is associated with increased severity of atopic dermatitis in children. Allergy Asthma Proc 25:181-184
27. Tamaki K, Kakinuma T, Saeki H, Horikawa T, Kataoka Y, Fujisawa T, Sato S, Takehara K, Nakahara T, Fukagawa S, Furue M (2006) Serum levels of CCL17/TARC in various skin diseases. J Dermatol 33:300-302. doi:10.1111/j.1346-8138.2006. 00072.x
28. Tanaka T, Tsutsui H, Yoshimoto T, Kotani M, Matsumoto M, Fujita A, Wang W, Higa S, Koshimoto T, Nakanishi K, Suemura M (2001) Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int Arch Allergy Immunol 125:236-240. doi:10.1159/000053821 (Pubitemid 32722295)
29. Thomas J (2008) Atopic dermatitis: current management strategies for adult patients. Dermatol Nurs 20:449-453,492
30. Trzeciak M, Glej J, Roszkiewicz J, Nedoszytko B (2010) Association of single nucleotide polymorphism of interleukin-18 with atopic dermatitis. J Eur Acad Dermatol Venereol 24:78-79. doi:10.1111/j.1468-3083.2009.03272.x
31. Wild JS, Sigounas A, Sur N, Siddiqui MS, Alam R, Kurimoto M, Sur S (2000) IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 164. 2701-2710 (Pubitemid 30115503)
32. Wollenberg A, Klein E (2007) Current aspects of innate and adaptive immunity in atopic dermatitis. Clinic Rev Allerg Immunol 33:35-44. doi:10.1007/s12016-007-0032-9 (Pubitemid 351514142)
33. Yamanaka K, Tanaka M, Tsutsui H, Kupper TS, Asahi K, Okamura H, Nakanishi K, Suzuki M, Kayagaki N, Black RA, Miller DK, Nakashima K, Shimizu M, Mizutani H (2000) Skinspecific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 165:997-1003 (Pubitemid 30484769)
34. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K (1998) IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161:3400-3407